CIK 0002056611 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Latigo Biotherapeutics, Inc.
Sign in to watch- Ticker
- LTGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832625838
- Phone
- 805-716-2927
- Business address
- 1300 RANCHO CONEJO BLVD., SUITE 305, THOUSAND OAKS, CA
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-1MEF Other S-1MEF
- CERT Other Certification
- 8-A12B Other Registration of Securities
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
Page 2 of 3 · 44 filings